8-K

Company

Royalty Pharma plc

Filed

February 11, 2026

Period of Report

February 11, 2026

Accession Number

0001802768-26-000002

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →